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Hidradenitis suppurativa (HS) is a debilitating
condition characterized by recurrent abscess forma-
tion, fistulas, and scarring that frequently involve the
axillae, gluteal folds, groin, and the inframammary
region. The disease process and subsequent surgical
interventions can lead to significant scarring and
functional impairment. HS and scarring are both
associated with damaging psychological effects.1
Traditional surgical excision and carbon dioxide
(CO2) laser excision with healing by secondary
intention are reported to be effective methods of
treatment for advanced HS but can lead to scar
formation.2,3 In a study in which 61 consecutive
patients underwent treatment for HS using CO2
excision in 185 sites, there were 2 episodes of
recurrence with follow-up between 1 and 19 years
postoperatively.4 Here we report the first case of a
patient whose scars, restricted mobility, and chronic
ulceration secondary to CO2 laser excision were
treated successfully with fractional CO2 laser.
CASE REPORT
The patient is a 21-year-old obese African-
American female with a history of stage III HS located
in the bilateral axillae, labia, groin, and upper medial
thighs. She underwent failed treatment with spiro-
nolactone, oral contraceptive pills, multiple courses
of oral antibiotics, topical benzoyl peroxide, and
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treatments, the patient underwent a series of 6
additional sessions. After completion, physical ex-
amination found numerous interconnected sinus
tracts, nodules, and extensive scarring in the left
axilla (Fig 1). The decision to pursue surgical
intervention was made, and she subsequently un-
derwent CO2 laser excision to the left axilla, as this
was the most severely involved area. The patient
tolerated the procedure well, and her woundwas left
to heal by secondary intention (Fig 2).
Recovery from CO2 laser excision was complicated
by chronic ulceration and scar contracture, which
caused restricted range of motion. When the patient
performed daily tasks, she would notice worsening
ulceration, butwith decreasedmovement of the upper
extremity, the lesions would begin to heal. Nine
months postoperatively, physical examination found
2 nonhealing erosions in the left axilla and scar
contracture (Fig 3). We hypothesized that high tension
in this areawas contributing to the chronic ulcerations.
As treatment, the patient underwent fractional ablative
CO2 laser treatment to thepalpable firmandcontracted
areas surrounding the ulcerations in the left axilla.JAAD Case Reports 2016;2:4-6.
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Fig 1. HS of the left axilla. There are multiple intercon-
nected sinus tracts, nodules, and significant scarring.
Fig 2. HS of the left axilla after CO2 excision.
Fig 3. HS of the left axilla 9 months after CO2 excision
with two chronic nonhealing ulcers.
Fig 4. HS of the left axilla after CO2 excision and 4
sessions of fractional CO2 laser treatment. The ulcers have
resolved with improved textural appearance of the scar,
and the patient has improved range of motion.
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by 5 to 6 weeks with the following laser parameters:
50 J of pulse energy, 5% density, and nominal 120-
m spot size with a fractional CO2 laser (Lumenis,
Inc, Yokneam, Israel). Pretreatment anesthesia with
forced cool air was used. The area was dressed with
petroleum jelly, and there were no reported adverse
events. By the third treatment, the erosions had
mostly healed with the exception of one area of
granulation tissue, but the textural appearance of the
scar was improved. By the fourth and final treatment,
the erosions were completely healed with only one
area of hypertrophic scar on the lateral aspect of the
left axilla. It should be noted that since the CO2
excision, the patient lost 14% of her body mass. We
hypothesize that because of improvement in disease
and mobility the patient was able to participate inmore physical activity. Sixteen months postopera-
tively the patient has no evidence of HS recurrence,
no deficits in range of motion, and an improved
texture and appearance of the scar (Fig 4).DISCUSSION
Currently, most treatments for HS focus on treat-
ing inflammatory lesions rather than any scarring and
resulting debility. There have been many recent
advances in scar treatments, particularly with laser
intervention. In 2004, Manstein et al5 first reported
the concept of fractional photothermolysis for skin
restoration. This technique involves the use of heat
to create microscopic columns of injury where
interspersed areas of healthy, noninjured tissue serve
as a reservoir of cells for wound healing. The thermal
injury leads to upregulation of procollagen
messenger RNA, several matrix metalloproteinases,
and cytokines, which are involved in the wound
healing process.6 Since the development of this
technique, fractional CO2 laser has shown efficacy
in the treatment of many different types of scars
including atrophic acne scars, mature burn scars,
restrictive scars, and hypertrophic scars.7,8
Deep FX settings were chosen for this treatment
because of a modest immediate photomechanical
release of tension in some restrictive scars, which is
seen after fractional laser tissue ablation.9 It is hy-
pothesized that this reduction of tension surrounding
the edges of the ulcer directly contributed to the rapid
healing in our patient.6 Additionally, in mature burn
scars there is an increase in type III collagen (seen in
fetal and scarless healing) after treatment with
fractional laser, likely leading to an improvement in
scar appearance, tension, and texture.8
Recently, Krakowski et al10 reported a case of a
pediatric patient whose HS was controlled with
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psychological distress over the appearance of crib-
riform scarring in the inframammary region. The
scarring was treated with 2 sessions of fractional CO2
laser separated by 2 months, which resulted in
reduced erythema, improved texture, pliability, and
appearance of the scar.10
Although the scarring in these HS patients had
different causes, it appears that the fractional CO2
laser has some efficacy in reducing morbidity in HS-
related scars. The rapid increase in both range of
motion and healing of chronic ulcers in our patient
supports previous research on the importance of
tension in chronic wounds. The combination of
CO2 laser excision with fractional laser treatment for
possible scar contracture may make treatment of
extensive disease with excision a more acceptable
treatment option. However, further prospective
studies are needed to determine the role of frac-
tional CO2 laser in the treatment of HS-related
scarring.
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